TY - JOUR
KW - Methamphetamine
KW - Opioids
KW - Injecting drug use
KW - Opioid substitution therapy
KW - Harm Reduction
KW - Polydrug use
KW - Co-injection
KW - qualitative
KW - Empirical Study
KW - Interview
KW - Qualitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Young Adulthood (18-29 yrs)
KW - Thirties (30-39 yrs)
KW - Motivation
KW - Drug Therapy
KW - Intravenous Drug Usage
KW - Opiates
KW - polydrug abuse
KW - Heroin
KW - Toxic Disorders
KW - article
KW - Australia
KW - 3340:Clinical Psychopharmacology
AU - Anna Palmer
AU - Nick Scott
AU - Paul Dietze
AU - Peter Higgs
A1 - 
AD - Behaviours and Health Risks Program, Burnet Institute, Melbourne, VIC, Australia anna.palmer@burnet.edu.au; Palmer, Anna,85 Commercial Road,Melbourne,Australia,3004,Behaviours and Health Risks Program, Burnet Institute,anna.palmer@burnet.edu.au
BT - Harm Reduction Journal
C5 - Opioids & Substance Use
DO - 10.1186/s12954-020-00360-9
JF - Harm Reduction Journal
LA - English
M1 - Journal Article
PB - BioMed Central Limited
PY - 2020
SP - 6
T1 - Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: A qualitative study
T2 - Harm Reduction Journal
TI - Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: A qualitative study
U1 - Opioids & Substance Use
U3 - 10.1186/s12954-020-00360-9
VL - 17
Y1 - 2020
Y2 - Feb 27
ER -